Although an increasing number of studies have revealed that CD276 is able to influence cancer progression via various molecular mechanisms, to date, no comprehensive pan-cancer analysis of CD276 has been carried out, and few single-cell analyses of CD276 in different types of cancer have been performed [16]. The gene discussed is CD276; the disease is cancer.